Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma.
109
mentions
- X 106
- News 2
- YouTube 1
Omar Hamdani
PubHawk tracks social media discussions for 1 article by authors named Omar Hamdani.
Mentions
109
Peak: 90 in Aug 2022
across 1 tracked article
Extended reach
679,537
potential audience
Total likes
185
Video views
17
Mentions per month
Aug 2022 – Apr 2024Where it's discussed
-
X / Twitter106 posts
-
News2 articles
-
YouTube1 videos
Tracked by PubHawk
Most discussed articles
From PubMed
All publications
Searching PubMed…